Literature DB >> 20147452

Function of activation loop tyrosine phosphorylation in the mechanism of c-Kit auto-activation and its implication in sunitinib resistance.

Jonathan P DiNitto1, Gayatri D Deshmukh, Yan Zhang, Suzanne L Jacques, Rocco Coli, Joseph W Worrall, Wade Diehl, Jessie M English, Joe C Wu.   

Abstract

The activation of receptor tyrosine kinases (RTKs) is tightly regulated through a variety of mechanisms. Kinetic studies show that activation of c-Kit RTK occurs through an inter-molecular autophosphorylation. Phosphopeptide mapping of c-Kit reveals that 14-22 phosphates are added to each mol of wild-type (WT) c-Kit during the activation. Phosphorylation sites are found on the JM, kinase insert (KID), c-terminal domains and the activation loop (A-loop), but only the sites on the JM domain contribute to the kinase activation. The A-loop tyrosine (Y(823)) is not phosphorylated until very late in the activation (>90% completion), indicating that the A-loop phosphorylation is not required for c-Kit activation. A sunitinib-resistant mutant D816H that accelerates auto-activation by 184-fold shows no phosphorylation on the A-loop tyrosine after full activation. A loss-of-phosphorylation mutation Y823F remains fully competent in auto-activation. Similar to WT and D816H, the unactivated Y823F mutant binds sunitinib and imatinib with high affinity (K(D) = 5.9 nM). But unlike the WT and D816H where the activated enzymes lose the ability to bind the two drugs, activated Y823F binds the two inhibitors effectively. These observations suggest that the A-loop of activated Y823F remains flexible and can readily adopt unactivated conformations to accommodate DFG-out binders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20147452     DOI: 10.1093/jb/mvq015

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  29 in total

1.  Structural basis for c-KIT inhibition by the suppressor of cytokine signaling 6 (SOCS6) ubiquitin ligase.

Authors:  Fahad Zadjali; Ashley C W Pike; Mattias Vesterlund; Jianmin Sun; Chenggang Wu; Shawn S C Li; Lars Rönnstrand; Stefan Knapp; Alex N Bullock; Amilcar Flores-Morales
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

Review 2.  Role of genetic and molecular profiling in sarcomas.

Authors:  Scott M Norberg; Sujana Movva
Journal:  Curr Treat Options Oncol       Date:  2015-05

Review 3.  Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases.

Authors:  Kenneth Verstraete; Savvas N Savvides
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

4.  Macrophage proliferation is regulated through CSF-1 receptor tyrosines 544, 559, and 807.

Authors:  Wenfeng Yu; Jian Chen; Ying Xiong; Fiona J Pixley; Yee-Guide Yeung; E Richard Stanley
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

5.  Phosphorylation of the activation loop tyrosine 823 in c-Kit is crucial for cell survival and proliferation.

Authors:  Shruti Agarwal; Julhash U Kazi; Lars Rönnstrand
Journal:  J Biol Chem       Date:  2013-06-26       Impact factor: 5.157

6.  The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.

Authors:  S Agarwal; J U Kazi; S Mohlin; S Påhlman; L Rönnstrand
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

Review 7.  Structural and functional properties of platelet-derived growth factor and stem cell factor receptors.

Authors:  Carl-Henrik Heldin; Johan Lennartsson
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-08-01       Impact factor: 10.005

8.  The strength and cooperativity of KIT ectodomain contacts determine normal ligand-dependent stimulation or oncogenic activation in cancer.

Authors:  Andrey V Reshetnyak; Yarden Opatowsky; Titus J Boggon; Ewa Folta-Stogniew; Francisco Tome; Irit Lax; Joseph Schlessinger
Journal:  Mol Cell       Date:  2014-12-24       Impact factor: 17.970

9.  Secondary mutations of c-KIT contribute to acquired resistance to imatinib and decrease efficacy of sunitinib in Chinese patients with gastrointestinal stromal tumors.

Authors:  Jing Gao; Ye Tian; Jian Li; Naiping Sun; Jiajia Yuan; Lin Shen
Journal:  Med Oncol       Date:  2013-03-02       Impact factor: 3.064

Review 10.  CSF-1 receptor signaling in myeloid cells.

Authors:  E Richard Stanley; Violeta Chitu
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.